184 related articles for article (PubMed ID: 12029432)
1. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?
Hempen C; Weiss E; Hess CF
Support Care Cancer; 2002 May; 10(4):322-8. PubMed ID: 12029432
[TBL] [Abstract][Full Text] [Related]
2. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
4. [Report of experience with stomach-protective therapy in high-dosage corticosteroid treatment of patients with brain tumors].
Hirschl M
Wien Med Wochenschr; 1988 Mar; 138(5):97-101. PubMed ID: 3388875
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
6. [Clinical control trial of methylprednisolone and dexamethasone in treatment of intracranial tumor edema].
Ding X; Mao B; Ju Y; Liu Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):327-9. PubMed ID: 12947730
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone increases hepatotoxicity of MTX in children with brain tumors.
Wolff JE; Hauch H; Kühl J; Egeler RM; Jürgens H
Anticancer Res; 1998; 18(4B):2895-9. PubMed ID: 9713483
[TBL] [Abstract][Full Text] [Related]
8. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
9. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
10. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
Hughes MA; Parisi M; Grossman S; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1423-6. PubMed ID: 16029802
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.
Naito M; Itoh K; Komatsu N; Yamashita Y; Shirakusa T; Yamada A; Moriya F; Ayatuka H; Mohamed ER; Matsuoka K; Noguchi M
Prostate; 2008 Dec; 68(16):1753-62. PubMed ID: 18767041
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients.
Ogawa K; Shikama N; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Kakinohana Y; Kinjo T; Yoshii Y; Ito H; Murayama S
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):705-13. PubMed ID: 14967424
[TBL] [Abstract][Full Text] [Related]
15. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques.
Paek SH; Audu PB; Sperling MR; Cho J; Andrews DW
Neurosurgery; 2005 May; 56(5):1021-34; discussion 1021-34. PubMed ID: 15854250
[TBL] [Abstract][Full Text] [Related]
16. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of 1 versus 3 days of dexamethasone as add-on therapy in children with streptococcal pharyngitis.
Niland ML; Bonsu BK; Nuss KE; Goodman DG
Pediatr Infect Dis J; 2006 Jun; 25(6):477-81. PubMed ID: 16732143
[TBL] [Abstract][Full Text] [Related]
18. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
[TBL] [Abstract][Full Text] [Related]
19. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
[TBL] [Abstract][Full Text] [Related]
20. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
